ClearBridge Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
3,146
-25
-0.8% -$9.27K ﹤0.01% 625
2026
Q1
$928K Hold
3,171
﹤0.01% 631
2025
Q4
$1.11M Sell
3,171
-60
-2% -$20.3K ﹤0.01% 636
2025
Q3
$1.04M Sell
3,231
-1,263
-28% -$393K ﹤0.01% 652
2025
Q2
$1.75M Sell
4,494
-223
-5% -$89.7K ﹤0.01% 617
2025
Q1
$2.05M Sell
4,717
-864
-15% -$347K ﹤0.01% 608
2024
Q4
$2.06M Sell
5,581
-218,182
-98% -$91.3M ﹤0.01% 618
2024
Q3
$116M Sell
223,763
-496
-0.2% -$265K 0.09% 214
2024
Q2
$122M Buy
224,259
+3,841
+2% +$2.03M 0.1% 198
2024
Q1
$114M Sell
220,418
-26,895
-11% -$13.4M 0.09% 234
2023
Q4
$117M Sell
247,313
-80,716
-25% -$37.3M 0.1% 211
2023
Q3
$143M Sell
328,029
-3,053
-0.9% -$1.38M 0.14% 165
2023
Q2
$147M Sell
331,082
-11,460
-3% -$5.29M 0.13% 165
2023
Q1
$158M Sell
342,542
-2,987
-0.9% -$1.42M 0.15% 149
2022
Q4
$177M Sell
345,529
-9,362
-3% -$4.75M 0.18% 134
2022
Q3
$161M Buy
354,891
+6,020
+2% +$2.88M 0.16% 137
2022
Q2
$168M Buy
348,871
+1,137
+0.3% +$562K 0.16% 138
2022
Q1
$171M Sell
347,734
-1,891
-0.5% -$864K 0.13% 159
2021
Q4
$162M Buy
349,625
+37,595
+12% +$15.8M 0.11% 179
2021
Q3
$116M Buy
312,030
+13,390
+4% +$5.09M 0.08% 211
2021
Q2
$114M Buy
298,640
+17,018
+6% +$6.5M 0.08% 219
2021
Q1
$101M Sell
281,622
-5,260
-2% -$1.69M 0.08% 217
2020
Q4
$92.1M Sell
286,882
-10,101
-3% -$3.1M 0.07% 220
2020
Q3
$79.8M Sell
296,983
-51,302
-15% -$13.8M 0.07% 217
2020
Q2
$91.6M Sell
348,285
-1,714
-0.5% -$457K 0.08% 193
2020
Q1
$79.5M Sell
349,999
-8,445
-2% -$2.3M 0.09% 194
2019
Q4
$108M Sell
358,444
-51,172
-12% -$14.1M 0.09% 192
2019
Q3
$98.3M Buy
409,616
+4,008
+1% +$1.1M 0.09% 200
2019
Q2
$114M Sell
405,608
-4,251
-1% -$1.16M 0.1% 181
2019
Q1
$118M Sell
409,859
-124,826
-23% -$36.1M 0.1% 182
2018
Q4
$140M Buy
534,685
+11,495
+2% +$3.16M 0.14% 152
2018
Q3
$143M Sell
523,190
-21,674
-4% -$5.63M 0.12% 168
2018
Q2
$130M Sell
544,864
-1,033
-0.2% -$239K 0.11% 180
2018
Q1
$120M Sell
545,897
-78,983
-13% -$18.6M 0.11% 172
2017
Q4
$141M Sell
624,880
-5,195
-0.8% -$1.11M 0.13% 161
2017
Q3
$120M Sell
630,075
-67,828
-10% -$12.9M 0.12% 177
2017
Q2
$131M Sell
697,903
-637
-0.1% -$114K 0.13% 161
2017
Q1
$116M Sell
698,540
-20,169
-3% -$3.21M 0.12% 178
2016
Q4
$103M Sell
718,709
-35,018
-5% -$4.69M 0.11% 165
2016
Q3
$94.5M Sell
753,727
-1,691
-0.2% -$218K 0.11% 173
2016
Q2
$99.2M Buy
755,418
+30,208
+4% +$4.13M 0.12% 171
2016
Q1
$101M Sell
725,210
-10,690
-1% -$1.43M 0.12% 167
2015
Q4
$103M Sell
735,900
-1,732
-0.2% -$239K 0.12% 172
2015
Q3
$103M Sell
737,632
-7,513
-1% -$1.13M 0.12% 173
2015
Q2
$122M Sell
745,145
-52,833
-7% -$8.44M 0.13% 166
2015
Q1
$123M Sell
797,978
-8,219
-1% -$1.17M 0.13% 166
2014
Q4
$101M Buy
806,197
+18,114
+2% +$2.24M 0.11% 186
2014
Q3
$94.3M Sell
788,083
-30,222
-4% -$3.47M 0.1% 186
2014
Q2
$88.1M Sell
818,305
-77,385
-9% -$7.97M 0.1% 195
2014
Q1
$89.2M Buy
895,690
+167,131
+23% +$15.1M 0.11% 185
2013
Q4
$67.3M Sell
728,559
-296,528
-29% -$26.3M 0.08% 235
2013
Q3
$85.7M Buy
1,025,087
+76,623
+8% +$6.57M 0.12% 175
2013
Q2
$77.6M Buy
+948,464
New +$71M 0.12% 181

Other funds holding ELV

ClearBridge Investments's ELV Position: Q2 2026 in Review

ClearBridge Investments reduced its Elevance Health (ELV) stake by 0.79% in Q2 2026, selling an estimated $9.27K and leaving 3,146 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #625.

ClearBridge Investments first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $177M in Q4 2022. 1,303 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ClearBridge Investments held 3,146 shares of Elevance Health worth $1.22M as of Q2 2026.
  • ClearBridge Investments sold 25 Elevance Health shares in Q2 2026, an estimated $9.27K.
  • Elevance Health made up ﹤0.01% of ClearBridge Investments's portfolio in Q2 2026, its #625 holding.
  • ClearBridge Investments first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • ClearBridge Investments's Elevance Health position peaked at $177M in Q4 2022.
  • 1,303 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.